Kosugi T, Nakamura M, Saitoh S, Kinjoh K
Department of Physiology, School of Medicine, University of the Ryukyus, Okinawa, Japan.
Int J Tissue React. 1991;13(3):123-9.
Ticlopidine hydrochloride 180 mg was given orally to rabbits and OKY-046 50 mg was simultaneously administered intravenously. Ticlopidine inhibited the platelet aggregation induced by ADP when the Ticlopidine was orally administered separately, but the platelet aggregation induced by PAF, collagen and arachidonic acid (A.a.) was not significantly decreased. Simultaneous administration of Ticlopidine and OKY-046, as compared to administration of Ticlopidine alone, led to a significant decrease in the platelet aggregation induced by A.a. and collagen. The simultaneous administration did not give rise to an additive or synergistic effect on the platelet aggregation induced by ADP.
给兔子口服180毫克盐酸噻氯匹定,并同时静脉注射50毫克OKY - 046。单独口服噻氯匹定时,它能抑制二磷酸腺苷(ADP)诱导的血小板聚集,但对血小板活化因子(PAF)、胶原蛋白和花生四烯酸(A.a.)诱导的血小板聚集没有显著降低作用。与单独给予噻氯匹定相比,同时给予噻氯匹定和OKY - 046可导致花生四烯酸和胶原蛋白诱导的血小板聚集显著降低。同时给药对ADP诱导的血小板聚集没有产生相加或协同作用。